Form 8-K - Current report:
SEC Accession No. 0001477932-24-008304
Filing Date
2024-12-26
Accepted
2024-12-26 15:17:33
Documents
18
Period of Report
2024-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avrw_8k.htm   iXBRL 8-K 35682
2 SETTLEMENT AGREEMENT WITH MUTUAL RELEASES avrw_ex101.htm EX-10.1 297106
3 SENIOR SECURED NOTE avrw_ex102.htm EX-10.2 596411
9 avrw_ex101img18.gif GRAPHIC 2207
  Complete submission text file 0001477932-24-008304.txt   1230947

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA avrw-20241215.xsd EX-101.SCH 5874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE avrw-20241215_lab.xml EX-101.LAB 13171
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avrw-20241215_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avrw-20241215_pre.xml EX-101.PRE 8249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avrw-20241215_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT avrw_8k_htm.xml XML 3554
Mailing Address 15233 VENTURA BLVD. SUITE 420 SHERMAN OAKS CA 91403
Business Address 15233 VENTURA BLVD. SUITE 420 SHERMAN OAKS CA 91403 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 241580782
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)